not tagged
not tagged
[]
three-year results from the evolut low risk trial have shown durable benefits of tavi compared to surgery regarding all-cause mortality or disabling stroke in patients with severe aortic stenosis at low surgical risk, john forrest reports #acc2023 
The international newspaper for cardiovascular specialists. For the latest #CardiovascularNews | Subscribe for free: https://t.co/x8Uwtv87xq